Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2Other 1

Conditions

Pain 1Opioid-Induced Constipation 1Neoplasms 1Constipation 1Cancer Pain 1Bronchiolitis Obliterans Syndrome 1

Interventions

Resistance Training 4Nutrition Assessment 4naloxegol 3Surveys and Questionnaires 3Exercise 3alvimopan 2Therapeutics 2Psychiatric Rehabilitation 2Oxygen 2Nutritional Status 2Mouthwashes 2Morphine 2Ketamine 2Interviews as Topic 2Fibroblast Growth Factor 7 2Counseling 2semaglutide 1naldemedine 1methylnaltrexone 1ma zi ren wan 1kang-lai-te 1hydrated silica gel-based toothpaste 1golotimod 1dexamethasone acetate 1dexamethasone 21-phosphate 1calcium phosphate 1auricularum 1aluminum hydroxide, magnesium hydroxide, drug combination 1Weights and Measures 1Walking 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Oxycodone × Other × Clear all
NCT00513656 2018-10-23

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

Mundipharma Research GmbH & Co KG

Phase 2 Completed
230 enrolled
Other

Bronchiolitis Obliterans Syndrome, Constipation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡